共 151 条
[1]
Zhang S(2019)Global, regional, and national burden of endometrial cancer, 1990–2017: results from the global burden of disease study, 2017 Front Oncol 19 1440-424
[2]
Gong TT(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-6794
[3]
Liu FH(2015)Expression of ER, PR, C-erbB-2 and Ki-67 in endometrial carcinoma and their relationships with the clinicopathological features Asian Pac J Cancer Prev 16 6789-220
[4]
Jiang YT(2010)Expression of ER, PR, and Her-2/neu in endometrial cancer: a clinicopathological study Asian Pac J Cancer Prev 11 215-1784
[5]
Sun H(2008)Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma J Med Assoc Thai 91 1779-254
[6]
Ma XX(1990)Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: clinical and histologic correlations Am J Clin Pathol 94 247-1390
[7]
Bray F(2004)Her-2/neu overexpression and amplification in uterine papillary serous carcinoma J Clin Oncol 22 3126-137
[8]
Ferlay J(1999)Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population based endometrial carcinoma study J Clin Oncol 151 1382-252
[9]
Soerjomataram I(2004)Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut off level Int J Gynecol Pathol 23 129-388
[10]
Siegel RL(2004)Immunohistochemical analysis of estrogen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium Acta Histochem 106 245-1313